AT1 receptor signaling pathways in the cardiovascular system

Pharmacological Research : the Official Journal of the Italian Pharmacological Society
Tatsuo KawaiSatoru Eguchi

Abstract

The importance of the renin angiotensin aldosterone system in cardiovascular physiology and pathophysiology has been well described whereas the detailed molecular mechanisms remain elusive. The angiotensin II type 1 receptor (AT1 receptor) is one of the key players in the renin angiotensin aldosterone system. The AT1 receptor promotes various intracellular signaling pathways resulting in hypertension, endothelial dysfunction, vascular remodeling and end organ damage. Accumulating evidence shows the complex picture of AT1 receptor-mediated signaling; AT1 receptor-mediated heterotrimeric G protein-dependent signaling, transactivation of growth factor receptors, NADPH oxidase and ROS signaling, G protein-independent signaling, including the β-arrestin signals and interaction with several AT1 receptor interacting proteins. In addition, there is functional cross-talk between the AT1 receptor signaling pathway and other signaling pathways. In this review, we will summarize an up to date overview of essential AT1 receptor signaling events and their functional significances in the cardiovascular system.

Citations

Jun 7, 2018·Physiological Reviews·Steven J ForresterSatoru Eguchi
Jun 16, 2018·Clinical Science·Alynne Carvalho-GalvãoMaria do Socorro de França-Silva
Jul 13, 2018·Exercise and Sport Sciences Reviews·Scott K PowersMatthew J Hinkley
Dec 6, 2017·Hypertension·Rhian M Touyz, Augusto C Montezano
Nov 2, 2018·PloS One·Alexander Perdomo-PantojaTalia Wegman-Ostrosky
Jul 10, 2020·The Journal of Clinical Hypertension·Kazuomi KarioUNKNOWN Hypertension Cardiovascular Outcome Prevention, Evidence in Asia (HOPE Asia) Network
Jul 28, 2020·American Journal of Physiology. Renal Physiology·Yongzhen ZhaoJian-Xiong Chen
Aug 25, 2019·International Journal of Molecular Sciences·Tatyana A Meyers, DeWayne Townsend
Jul 29, 2020·Hypertension Research : Official Journal of the Japanese Society of Hypertension·Fangyuan ChenQin Xue
Oct 1, 2020·Heart Failure Reviews·Noé Francisco Garay-GutiérrezCarlos Enrique Guerrero-Beltrán
Jul 25, 2018·Clinical Science·Eliete Dalla Corte FrantzAntonio Claudio Lucas Nobrega
Jul 19, 2020·International Journal of Molecular Sciences·Stephanie CicaleseSatoru Eguchi
Feb 17, 2018·Journal of Neuro-oncology·Alexander Perdomo-PantojaTalia Wegman-Ostrosky
Apr 10, 2019·International Journal of Molecular Sciences·Elena De AngelisAda Popolo
Dec 14, 2018·Experimental and Therapeutic Medicine·Haiming DangHongjia Zhang
Aug 16, 2019·Bioscience Reports·Jia LiuJiyan Leng
Apr 8, 2020·Advances in Pharmacological and Pharmaceutical Sciences·Marcos André Soares LealValério Garrone Barauna
Sep 4, 2018·JACC. Basic to Translational Science·Laurel A GrisantiWalter J Koch
Oct 27, 2020·Frontiers in Endocrinology·Julia HanchardSteffen-Sebastian Bolz
Feb 1, 2021·Biochemical and Biophysical Research Communications·Yingxuan WangXiao Chen
Feb 8, 2021·Nutrition, Metabolism, and Cardiovascular Diseases : NMCD·Matteo NardinGiuseppe De Luca
Feb 13, 2021·Cardiovascular Research·Marcin CzepielPrzemysław Błyszczuk
Apr 3, 2021·Molecular and Cellular Endocrinology·Elena Cantero-NavarroAlberto Ortiz
Mar 31, 2021·Molecular and Cellular Endocrinology·Fitra RiantoMatthew A Sparks
Apr 17, 2021·Frontiers in Cellular and Infection Microbiology·Ashok KumarNiraj Kumar
May 6, 2021·International Journal of Molecular Sciences·Michaela AdamcovaFedor Simko
May 11, 2021·American Journal of Physiology. Renal Physiology·Matthew A SparksThomas M Coffman
May 14, 2021·Circulation Research·Xiaomin SongJing Wang
Jun 8, 2021·Trends in Pharmacological Sciences·Fei GuoAmy Pointon
Jul 3, 2021·International Journal of Molecular Sciences·Céline DelaitreFrançois Dupuis
Jul 13, 2021·Biochemical Pharmacology·Robert EckenstalerRalf A Benndorf
Jul 21, 2020·Biomedicine & Pharmacotherapy = Biomédecine & Pharmacothérapie·Gaojun WuZhouqing Huang

❮ Previous
Next ❯

Related Concepts

Related Feeds

Cardiovascular Diseases: Risk Factors

Cardiovascular disease is a significant health concern. Risk factors include hypertension, obesity, dyslipidemia and smoking. Women who are postmenopausal are at an increased risk of heart disease. Here is the latest research for risk factors of cardiovascular disease.